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The present study explores accuracy in estimating blood glucose levels (BGL) in children
with type 1 diabetes and analyzes the kinds of symptoms and cues which they use to
estimate their BGL. Forty two children with type 1 diabetes completed a SI/IC-3 scale
consisting of 28 items (22 symptoms and 6 feelings), indicating those which they perceived
at the time and their intensity. They estimated their BGL and gave reasons for their
estimation, before having a blood glucose level analysis performed. The results indicated
great variability in the accuracy of estimating BGL. They showed failures in the correct
discrimination of symptoms of hypoglycemia as well as the presence of false beliefs
regarding indicative symptoms of hyperglycemia, and the absence of symptoms as an
indicator for euglycemia, beliefs which provoke different and frequent errors in the
estimation of BGL. Correct use of external signs is shown to be related to correct
estimations of normal BGL, as well as hypoglycemia and hyperglycemia. We discuss the
implications these results could have on designing psychological intervention procedures
for diabetics in the form of training programs to discriminate BGL accurately, taking into
account these findings and previous studies completed in the same field.
Keywords: type 1 diabetes, estimating BGL, symptom discrimination, internal cues, external
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El presente estudio explora la precisión en la estimación de los niveles de glucosa en
sangre (NGS) en niños con diabetes tipo I y analiza el tipo de síntomas o señales en
las que se basan para estimar sus NGS. 42 niños con diabetes tipo I completaron una
Escala SI/IC-3 compuestas por 28 ítems (22 síntomas y 6 estados de ánimo), señalando
las que percibían en ese momento y la intensidad, y estimaron el NGS indicando las
razones de su estimación, antes de realizar su análisis de glucosa en sangre. Los
resultados indican una gran variabilidad en la precisión en la estimación del NGS, y
muestran fallos en la correcta discriminación de los síntomas señales de hipoglucemias,
y la presencia de falsas creencias sobre síntomas indicativos de hiperglucemias y sobre
la ausencia de síntomas como indicador de normoglucemia, creencias que provocan
diferentes y frecuentes errores en la estimación de los NGS. El uso adecuado de las
señales externas se muestra relacionado con la estimación correcta de los NGS tanto
normales como hipoglucémicos e hiperglucémicos. Se discuten las implicaciones que
estos resultados pueden tener para el diseño de procedimientos de intervención psicológica
en diabetes en forma de programas de entrenamiento en discriminación de NGS que
tengan en cuenta estos hallazgos y los de estudios previos en la misma línea.
Palabras clave: diabetes tipo I, estimación NGS, discriminación síntomas, señales internas,
señales externas
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Diabetes mellitus is a chronic systemic disease that
affects every aspect of the patients’ lives. It can develop at
any age and requires complex and continuous treatment.
The patients’ demeanor is of extreme importance because
treatment is often self-administered and needs to be modified
constantly. This disease represents one of the most common
chronic disorders in infancy and adolescence, with a
prevalence of approximately 1.7 affected out of 1000 people
aged under 20. In Spain, data show that 5 out of every 1000
children between the ages of 1 and 4, and 2 out of every
1000 children between 5 and 14 years of age suffer from
Type 1 diabetes. According to these data of incidence and
prevalence of diabetes in children, there are more than
18,000 children younger than 15 with Type 1 diabetes, and
every year there will be approximately 700 new cases
(Beléndez, Ros, & Bermejo, 1999).
The active and vital role of the patient in controlling the
illness, along with the peculiar and complex characteristics
of the biobehavioral regulatory mechanism of blood glucose
levels distinctive to diabetes (see Gil Roales-Nieto & Vílchez
Joya, 1993), makes the role of mental health essential.
Mental health is vital to good metabolic control (the ultimate
goal of treatment) and to solving the multiple inconveniences
and problems these patients face the moment they are
diagnosed, and during the tiring day-to-day routine involved
in living with a disease that has such a high psychological
demand. 
Diabetes is an endocrine and metabolic disease that
affects the ability of the pancreas to secrete insulin, the
hormone which “allows” glucose to be used by cells.
Consequently, glucose cannot be metabolized by cells.
Glucose resulting from the breakdown of ingested food
remains in the bloodstream without being able to fulfill its
energy-providing function, due to the total or partial lack
of this hormone.
There are various types of diabetes, but the two most
important are insulin- dependant diabetes mellitus, or Type
1 (IDDM), and non-insulin dependent diabetes mellitus, or
Type 2 (NIDDM). Although Type 2, or adult-onset diabetes,
is also a very serious chronic illness, we will focus on Type
1 diabetes as the subject of our study. This type of diabetes
requires the administration of insulin in order for the patient
to survive, and in general, is the result of a destructive
process involving the cells of the pancreas, which produces
insulin (beta cells of the islets of Langerhans), and usually
appears early in life. It is considered an autoimmune disease
characterized by the progressive destruction of beta cells
in the pancreas and the consequent decrease in its ability
to produce insulin. This produces severe metabolic
deterioration whose principal characteristic is the inability
to metabolize glucose and its accumulation of glucose in
the bloodstream, which can, inevitably, lead to death if not
treated.
Hyperglycemia is defined as an elevation of blood
glucose level (BGL) to above normal limits (a maximum
level is considered to be 180mg/dl) and that characterizes
untreated diabetes. However, as a consequence of imbalances
during treatment, another acute complication, with severe
psychological impact on the patient, can occur. This
complication is hypoglycemia, defined as BGL below
80mg/dl. Hypoglycemia usually appears abruptly due to
hyperinsulinism caused by the imbalance between glucose
and available insulin. There are four situations associated
with this occurrence: an overdose of insulin, delayed eating
or an imbalance of appropriate food intake, an inappropriate
level of physical exercise, and alcohol consumption. 
Because of the diabetics’ comprehensive and complex
diet, patients should be trained to manage its various
components. A prime clinical characteristic of diabetes is
BGL instability, a variable that is automatically regulated
in non-diabetics and maintains a narrow fluctuation between
approximately 70 and 150mg/dl. Diabetics can vacillate
between very low figures, which, in the short term, can
endanger the patient’s life and very high figures, which can
provoke medium term consequences. This is why diabetic
patients must learn to be aware of these sudden changes in
BGL and to correct them.
From a psychological perspective, treatment of Type 1
diabetes is a self-monitoring process in which patients must
modify their behavior (e.g., insulin administration, diet,
exercise, etc.) in order to maintain their BGL within the
established normal range (Gil Roales-Nieto, 2000a; Gil
Roales-Nieto & Vílchez Joya, 1993; Gonder-Frederick, Cox,
& Ritterband, 2002). Therefore, diabetic patients may have
to vary the dosage and/or type of insulin they inject, maintain
or change their diet, and do more or less exercise depending
on variations in their BGL, trying to maintain levels within
a normal range whenever possible, so as to avoid both
hypoglycemia and hyperglycemia. Self-monitoring is only
possible if accurate and immediate feedback regarding BGL
is available. Given the numerous occasions throughout the
day when this information is not available by an objective
measure, diabetic patients must adapt to a functional outline
called the “gluco-insulin biobehavioral feedback system”
(Gil Roales-Nieto, 2000b, 2004), which combines a complex
process of making decisions based on objective and
subjective assessments of BGL. 
Routine self-monitoring of blood glucose (SMBG),
performed with patients’ samples of capillary blood, is an
essential component in the treatment of diabetes that allows
patients to know their exact BGL in less than a minute. But
even though the majority of patients receive training and
instruction in SMBG implementation as part of their
treatment, data indicate weak adherence to SMBG (Jones,
Remley, & Engberg, 1996; Karter, Ferrara, Darbinian,
Ackerson, & Selby, 2000). Reasons for the low compliance
to SMBG include high cost and the relative aversion to
taking repeated blood samples, or the numerous obstacles
that compete with its compliance such as incompatible
schedules, long working hours away from home, etc. (de la
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Fuente & Gil Roales-Nieto, 1994; Luzoro & Gil Roales-
Nieto, 1993; Nyomba, Berard, & Murphy, 2002; Zgibor &
Simmons, 2002). Furthermore, diabetic patients frequently
find themselves in situations where it is impossible to
perform SMBG, and can only estimate their BGL based on
the presence or absence of the symptoms and cues they
believe to be associated with BGL variations (technically
called internal cues). Estimations are also based on their
knowledge of the disease, the value of distinct parameters
of the principle aspects of treatment, and the vital events
related to BGL variations (e.g., insulin, diet, stress levels,
rest-activity habits, etc.), which are technically called external
cues (Gil Roales-Nieto, 1988, 1991a, 1991b). In the life of
any diabetic patient, it is normal to perform “estimation
trials” dozens of times throughout the day, that is, evaluations
of BGL consisting of estimations based on internal and
external cues. Therefore, it is appropriate to address this
complex behavior, studying the variables on which it
depends, the processes involved, and to search for
intervention procedures that improve and enhance diabetic
control.
Various studies out of the accuracy with which adult
diabetic patients estimate their BGL based on internal cues
or symptoms have been carried, finding a reduced number
of clinically precise estimates, that is, those in which patients
were close to estimating their actual BGL (Cox et al., 1991,
2001), and that error was common. Likewise, in the few
cases that have been studied, estimates by diabetic
adolescents and children also seemed to be imprecise, with
only an average of between 30 and 40% accurate estimations
(de la Fuente Arias & Gil Roales-Nieto, 1994; Gonder-
Frederick, Zinder, & Clarke, 1991; Nurick & Jonson, 1991).
During the past few decades, various research groups
have continued investigate estimation management and have
developed training procedures for estimating BGL. These
procedures teach diabetic patients to correctly estimate their
BGL by evaluating its variation with the maximum possible
precision when it is impossible to obtain an objective
reading via SMBG. For example, in the USA, Daniel Cox
and his team of collaborators (Cox, Carter, Gonder-
Frederick, Clarke, & Pohl, 1988; Cox et al., 1991; Cox,
Gonder-Frederick, Julian, & Clarke, 1994; Cox et al., 2001)
have developed training procedures primarily based on the
use of internal cues from studies that indicated the highly
idiosyncratic nature of symptoms specific to hyperglycemia
as well as hypoglycemia (Cox, Gonder-Frederick, Antoun,
Cryer, & Clarke, 1993; Freund, Johnson, Rosenbloom,
Alexander, & Hansen, 1986; Gonder-Frederick, Cox,
Bobbitt, & Pennebaker, 1986).
Moreover, a detailed analysis of the idiosyncratic pattern
of symptoms shown by patients has increased the customary
presence of false beliefs about symptom-blood glucose
relationships and the occurrence of misperceptions of
symptoms contingent with extreme BGL. Thus, many
patients may focus on symptoms that are actually false
signals while ignoring others that truly indicate variations
in BGL and can involve serious clinical consequences
(Diamond, Massey, & Covey, 1989; Gil Roales-Nieto &
Vílchez Joya, 1993; Gonder-Frederick et al., 1986). Similar
findings have also been reported in diabetic children and
adolescents (Freund et al., 1986; Wiebe, Alderfer, Palmer,
Lindsay, & Jarrett, 1994).
Other studies carried out in Spain, USA, and Chile by
Gil Roales-Nieto and his collaborators, have led to the
development of training procedures that include the
preferred use of external cues (de la Fuente Arias & Gil
Roales-Nieto, 1994; Gil Roales-Nieto, 1998, 1991a; Luzoro
& Gil Roales-Nieto, 1993), taking into consideration those
circumstances which produce BGL variations and whose
occurrence or effects are perceivable or sensitive to
recognition by the patient (Gil Roales-Nieto, 1998; Gil
Roales-Nieto & Vílchez Joya, 1993; Korn & Matos, 2001).
Actually, in two studies carried out with diabetic
adolescents, the employment of these kinds of cues showed
higher efficiency in BGL assessment as compared to relying
on internal cues. The results of the first study showed that
external cue training, using glycemic outlines as a temporary
training standard, is effective in increasing the accuracy of
patients’ estimations, as well as in secondary improvement
of various metabolic control ratings (Luzoro & Gil Roales-
Nieto, 1993). In the second of these studies, the authors
compared external cue training with other procedures such
as feedback or internal cue training. Results indicated the
superiority of external cue training (de la Fuente Arias &
Gil Roales-Nieto, 1994).
If blood glucose (BG) awareness training is an important
part of a diabetics’ education, it is even more important in
the case of adolescent and pre-adolescent patients, as diabetic
control in these kinds of patients involves special age-related
complications.
On the other hand, before reaching adolescence,
children are less likely to present problems such as
physiological resistance to insulin or the negativity and
typical adolescent rebellion that can often complicate this
kind of intervention (Bryden et al., 2001; Dunger, 1992;
Guthrie, Bartsocas, Jarosz-Chabot & Konstantinova, 2003).
However, very few studies have been carried out on the
estimation management of diabetic children during pre-
adolescence (Freund et al., 1986; Wiebe et al., 1994), which
could provide keys for the adaptation of BG awareness
training procedures to this group of patients. Furthermore,
the few studies that were carried out fail to analyze which
kinds of internal and/or external cues subjects really use
when estimating their BGL.
The aims of this study include the analysis of accuracy
in BGL estimation in pre-adolescent diabetic children with
Type 1 diabetes, and the determination of the type of cues
these children use to make their estimations. A third goal
is the evaluation of the possible relationships between
symptoms and extreme BGL in diabetic children.
Method
Participants
Forty two children participated in this study (22 girls
and 20 boys), aged between 9 and 14 years (M =11.3, SD
= 1.8), and diagnosed with Type 1 diabetes with a duration
ranging from 1 to 12 years (M = 5.3, SD = 3.2). Participants
were selected from children attending two summer camps
for diabetic children. In both camps, there were four
established daily BG controls, one before each main meal
(breakfast, lunch, and dinner) and before going to bed. In
addition, children could request a BG analysis from the
counselors if they suspected they were experiencing levels
of hypo or hyperglycemia.
Instruments
The following instruments were used during this study:
The SI/IC-3 Symptom Scale, based on 22 symptoms
and 6 feelings, selected from previous investigations
developed by Gil Roales-Nieto (1993) and employed in
the aforementioned studies, which groups symptoms
normally associated with states of hypo- and hyperglycemia
and is used to evaluate symptoms of perceived feelings
and their intensity, on a 3-point rating scale (1 = slight, 2
= moderate, 3 = a lot). It also requires an exact BGL
reading, first in general and subsequently with an exact
number, allowing subjects to express their reasons for the
estimations given.
Paper to collect spontaneous requests for SMBG, on
which the time of the test was noted, as well as the patient’s
BGL estimation and the perceived symptoms at the time of
the request, indicating intensity.
Glucometers (Esprit, Bayer Laboratories) and their
corresponding reactive strips to obtain actual BGL from
capillary samples. BGL was measured using milligrams of
glucose per deciliter of blood, a measurement known and
used by all diabetic patients and the measurement in which
glucometers provide their results. Thus, subjects estimated
their BGL with this measurement, while classifying it as
high (hyperglycemia), low (hypoglycemia), or normal
(euglycemia). The estimated BGL, as well as the actual
levels obtained by the controls, were classified either as
hypoglycemia (< 80 mg/dl), euglycemia (80-180 mg/dl), or
hyperglycemia (> 180 mg/dl).
To gauge BGL estimation management, and in order to
assess the adaptive value of the patients’ estimation for
diabetic control, the estimations were categorized as: 
1. Clinically precise or correct: those estimation trials
which revealed clinical correspondence between the patient’s
estimated BGL and the actual BGL (e.g., the participant
reported suffering from hypoglycemia and the actual BGL
indicate that this is true). Correct estimates include correctly
perceiving hypoglycemia, hyperglycemia, and euglycemia. 
2. Clinically imprecise or erroneous: those estimation
trials which revealed a lack of such correspondence (e.g.,
the patient reports suffering from hypoglycemia and the
actual BGL is normal). Two types of errors can be made
according to guidelines established by Gil Roales-Nieto
(1988, 1993): (a) false hypoglycemia and false hyperglycemia
(e.g., when hypoglycemia is not present and patients estimate
their BGL as hypoglycemic) and (b) actual hypoglycemia
or unperceived hyperglycemia (e.g., when patients estimate
their BGL as normal and they are actually hyperglycemic).
A third type of error we will call inverse estimation is a
combination of the previous two and implies an estimation
contrary to the actual BGL (e.g., an estimation of
hypoglycemia when the actual BGL indicates hyperglycemia
and vice versa). This can lead to making a decision with
dire consequences, as the patient might self-correct the
estimated BGL, heading in the opposite direction of the
treatment that is actually necessary, given the actual BGL. 
An important aspect when analyzing estimation
management and its errors is to determine which information
patients use to make their estimations. In order to distinguish
between the two main possibilities and to organize the
analysis, when patients report having based their estimations
on the perception of a symptom or on “how they feel,” we
will say that the patients were using “internal cues” (i.e.,
answers such as “because I was hungry,” “because I was
tired,” “because I didn’t feel anything,” etc.). When
individuals report having based their estimations on diet,
exercise performed, administered insulin, or previous BGL,
we will say that they were using “external cues.”
Procedure
Starting on the second day of their stay and during the
following days at camp, participants completed the SI/IC-
3 scale before each routine analysis (before breakfast, lunch
and dinner). They did not complete the scale before going
to bed for several reasons, such as they were tired, the
general difficulty of filling in the scale, etc. In addition,
when a child requested a BG analysis from a counselor, a
form was filled out, stating the time of the analysis, the
child’s BGL estimation, and chief symptoms perceived, also
indicating their intensity. An estimation trial was considered
complete whenever participants completed the scale and
their actual BGL was obtained, whether it was within the
daily routine trials or in trials that were requested voluntarily.
In each estimation trial, the following steps were taken:
1. Completion of the symptoms scale for the presence or
absence of each cue along with its intensity in the former case.
2. Estimation of the BGL range (choosing between 3
options: hyperglycemic, hypoglycemic, or normal.)
3. Making a tangible estimation, indicating the exact BGL.
4. Giving all the reasons for arriving at their estimations.
5. Performing a BG analysis using a glucometer and
noting the result.
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Results
During the study, a total of 959 estimation trials were
completed by the participants with an average of 23 trials
per individual (SD = 4), ranging between 16 and 32 trials.
We evaluated the accuracy in estimating BGL for each
participant using two results: (a) the error in estimation,
obtained as the average of the differences in absolute value
between the actual BGL and the estimation given in each
trial; and (b) the correlation between estimated and actual
BGL. Results are shown in Table 1.
The average value of the correlations between estimated
BGL values and actual BGL is moderate (r = .41), and the
data range (-.21 to .84) shows the large individual differences
observed when estimating BGL. For example, although 18
individuals had statistically significant correlations, which
would indicate an acceptable level of accuracy in the
estimation, another 5 participants had negative correlations,
revealing a very low capacity for performing correct
estimations. The average estimation error also showed a
moderately high BG level (63.8mg/dl) and a broad range
(26.8 to 120.9mg/dl), which confirms what the correlations
between estimated and actual BGL indicated. Keep in mind
that an estimation error greater than 20 or 30mg/dl would
be considered a potentially dangerous error in diabetic control,
especially when the actual BGL is bordering on normal levels.
As far as the quality of the estimation, which can also be
seen in Table 1, participants showed a greater percentage of
precision than errors, 57.7% versus 43.4%, t = 3.564, p =
.001). Among the errors committed, participants showed a
greater percentage of undetected episodes than false
estimations, 23.8% versus 14.7%, t = 3.104, p< .01, and
among the undetected episodes, more were hyperglycemic
than hypoglycemic, 16.3% versus 7.5%, t) = –4.014, p< .001.
There were, however, no significant differences observed
between the estimations of false hypoglycemia and false
hyperglycemia, or between the two types of possible inversions
(estimated hypoglycemia with actual hyperglycemia and
estimated hyperglycemia with actual hypoglycemia). 
We evaluated the possible relationships of various
participant characteristics such as age, duration of diabetes,
average real BGL values, and BGL variability with the
precision for estimating BGL, more specifically, with the
average estimation error using t tests. Using the averages of
the sample, we created contrast groups for age (average 11
years), duration of diabetes (average 4.5 years), average BGL
value (165.8 mg/dl), and BGL variability (average 84.3
mg/dl). We found a statistically significant relationship with
average BGL values, 51.7 versus 74.7 mg/dl, t = –4.14, p <
.01, and with BGL variability, 54.7 mg/dl versus 72.8 mg/dl,
t = –3.01, p < .01, but not with age or duration of illness.
In order to analyze estimation management and its errors,
we used the information provided by the participants about
on what they based their estimations, distinguishing between
the use of internal and external cues. In Table 2, we present
the average percentage of estimation trials in which
participants used internal cues, external cues, or a combination
of both. The results indicate greater usage of internal cues
compared to external cues or a combination of both, F =
120.99, p < .001.
Table 1
Means, Range and Standard Deviations of Accuracy of BGL Estimations
Mean                                    Range                                   SD
Estimation error (in mg/dl) 63.8 26.8 — 120.9 21.25  
Correlation estimated/actual BGL .41 –.21 — .84 .26  
Correct trials (%) 57.7% 23.6 — 88.7 13.82  
Detected Hypoglycemia 16.3% 0 — 50 11.67  
Detected Hyperglycemia 17.0% 0 — 71.4 16.12  
Detected Euglycemia 24.3% 0 — 68.4 16.49  
Erroneous trials (%) 43.4% 15 — 76.2 12.48  
Hypo and Hyperglycemia 23.9% 9.1 — 56.2 11.09  
Undetected     
False Hypo- and Hyperglycemia 14.7% 0 — 44.4 11.10  
Inverse estimations 4.8% 0 — 28.6 6.21
Table 2
Percentage of Trials Using Internal and/or External Cues
Mean                                    Range                                  SD
Use of external cues (% of trials) 17.7 0 — 81 22.2  
Use of internal cues (% of trials) 70.7 0 — 100 29.1  
Use of internal and external cues (% of trials) 1.7 0 — 25 4.3  
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In the attempt to precisely assess estimation management,
we analyzed the internal or external cues indicated by
participants in the estimation trials as qualifying as correct
as well as erroneous, calculating the percentage of individuals
who indicated each cue in at least one trial.
In the first case, correct estimations, regarding correctly
perceived hypoglycemia (see Figure 1), participants more
frequently used [internal] symptom cues such as feeling dizzy
(61.1%) or trembling (27.8%), as well as various combinations
of two or more cues (38.9%) such as feeling dizzy and
trembling, feeling dizzy and tired, feeling dizzy and having
blurry vision, etc. Other less frequently reported symptoms
were feeling hungry, nervous, tired, having a stomach ache,
and headache. As can be seen in Figure 2, in the trials where
hyperglycemia was correctly perceived, the opposite occurred:
participants primarily used external cues such as the values
of previous BGL trials (31.2%), diet (18.7%), physical exercise
(15.6%), insulin (12.5%), or a combination of these (15.6%),
and less frequently, they used internal cues such as drowsiness
(15.6%), dry mouth (9.3%), or a combination of two or more
cues (15.6%) such as thirst and dry mouth, drowsiness and
dry mouth, etc. Regarding correct euglycemia estimations
(see Figure 3), the results showed that participants based their
estimations on general judgments such as “feeling well”
(71.1%), or the absence of symptoms or sensations (42.1%),
and, to a lesser degree, on the use of external cues such as
values of previous BGL trials (15.8%), diet (13.2%), physical
exercise (10.5%), or a combination of these (18.4%).
Figure 2. Percentage of participants who used each cue (internal or external) in perceived  hyperglycemia trials. 
Figure 1. Percentage of participants who used each cue (internal or external) in perceived hypoglycemia trials. 
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In trials qualifying estimations as imprecise or erroneous,
the results with regard to false hypo- or hyperglycemia
estimations (see Figure 4) showed that participants preferred
to use symptoms or internal cues such as feeling dizzy
(46.7%), trembling (13.3%), or feeling tired (13.3%) in the
cases resulting in false hypoglycemia. Cues such as dry
mouth (14.3%) or a combination with others such as
drowsiness, bad taste in the mouth, or urge to urinate
(28.6%) were the most common in the trials that resulted
in false hyperglycemia estimations. In a few cases, the use
of external cues resulted in an estimation of false
hypoglycemia and false hyperglycemia except, in the latter
case, when administered insulin was used as a cue
(14.3%).
Regarding the other kinds of errors in estimations, in
the cases of actual hypoglycemia and hyperglycemia that
were unperceived (see Figure 5), the majority of the
participants indicated having used general sensations such
as “feeling well” or “not feeling anything” or the absence
of typical symptoms related to hypo- and hyperglycemia.
In these cases, we observed greater use of external cues
with respect to false alarms.
Lastly, in the estimation trials which resulted in an
inverse estimation regarding the actual BGL value (see
Figure 6), we observed a large difference between the two
possible cases, given that, whereas, in the case of estimated
hypoglycemia with actual hyperglycemia, the most
commonly used cue was feeling dizzy (56.2%) and, in the
Figure 4. Percentage of participants who used each cue (internal or external) in false hypo- and hyperglycemia trials. 
50
45
40
35
30
25
20
15
10
5
0
Dizzy Two or more  Trembling Tired  Hungry Feeling Headache   Dry mouth    Urge to Feeling                     Previous    Exercise Insulin
internal cues                                                   bad                                  urinate well              trials
INTERNAL CUES EXTERNAL CUES
Figure 3. Percentage of participants who used each cue (internal or external) in perceived euglycemia trials. 
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case of estimated hyperglycemia with actual hypoglycemia,
lack of exercise (27.3%) was the most common cue.
Regarding the procedure used in this study, for ethical
reasons, we were aware of the actual BGL immediately
following each analysis. This raised the possibility that it
could be used as feedback, which would allow an
improvement in estimation accuracy. To determine whether
this effect occurred, we performed a repeated measures
analysis of variance, comparing estimation accuracy at
different periods (the beginning, middle, and end of the
study), and used the errors in estimation as a dependant
variable. The results showed no significant differences in
the accuracy of estimations throughout these periods, F =
0.004, p > .05.
Lastly, to determine the number of BGL-related
symptoms in each participant, we calculated Spearman’s
intra-subject correlations between each symptom and the
actual BGL data obtained. Thus, for each individual, we
calculated a total of 28 correlations, at a significance level
of p < .05. In order to increase the validity of the symptom
data, correlations were calculated between the intensity levels
reported for each symptom in the different trials and the
actual BGL value obtained on each occasion.
As pointed out by Gonder-Frederick, Cox, Bobbitt and
Pennebaker (1989), at the time these correlations were
obtained, BGL values could be treated either as categorical
variables (e.g., low, normal, or high levels, equivalent to the
ranges of hypoglycemia, euglycemia, and hyperglycemia,
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Figure 6. Percentage of participants who used each cue (internal or external) in inverse estimation trials. 
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Figure 5. Percentage of participants who used each cue (internal or external) in unperceived hyper- or hypoglycemia trials. 
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respectively) or as continuous variables. As previous studies
have shown that the patterns of symptoms obtained with both
methods are practically identical (Gonder-Frederick et al.,
1986; Pennebaker et al., 1981), we decided to treat the BGL
values as continuous variables, following the example of
Gonder-Frederick et al. (1989). After examining the results,
a relationship between a symptom and a certain BGL was
noted if their correlation was statistically significant. A positive
correlation coefficient indicates that a symptom is related to
hyperglycemic BGL, whereas a negative correlation coefficient
indicates that a symptom is related to hypoglycemic BGL
(Gonder-Frederick et al., 1989; Pennebaker et al., 1981).
The total of all BGL values of all participants was within
a range of 30mg/dl to 574 mg/dl (M = 165.5 mg/dl; SD =
94.5). The frequency distribution showed that 207% of the
BGLs were hypoglycemic (< 80 mg/dl), 40.6% were
euglycemic (80-180 mg/dl), and 38.7% were hyperglycemic
(> 180 mg/dl). One individual neither presented a
hyperglycemic BGL nor showed a positive correlation
coefficient, which indicates the existence of predictive
symptoms of high BGL. In addition, two individuals neither
presented hypoglycemic BGL nor did they have negative
correlation coefficients, which indicates the existence of
predictive symptoms of low BGL.
The results of the intra-subject correlations analysis
showed that only for four persons, the correlations between
symptoms and BGL were nonsignificant, and for 18
participants, there was only a significant correlation for one
symptom. Thirteen participants presented significant
correlations with hypoglycemic as well as hyperglycemic
BGLs, 12 with hyperglycemic BGL only, and 13 with
hypoglycemic BGL only. Taking all the participants into
account, we found a greater number of correlations with
hyperglycemic BGL than with hypoglycemic BGL (53 vs.
33). For each item on the scale, we calculated the percentage
of individuals for which a symptom correlated with a low
or high BGL. The results are shown in Table 3. The symptom
that correlated the most frequently in persons with low BGL
Table 3
Percentage of Participants for Whom each Symptom was Significantly Related to BGL
Perceived symptom                                            Low BGL High BGL Total
Headache 4.8 9.5 14.3  
Feeling tired/ weak 2.4 7.1 9.5  
Stomach ache or discomfort 2.4 11.9 14.3  
Feeling sluggish or lazy 4.8 4.8 9.6  
Feeling dizzy 26.2 0 26.2  
Bad taste in the mouth 2.4 0 2.4  
Awake and full of energy 2.4 7.1 9.5  
Dry mouth 0 7.1 7.1  
Feeling relaxed 0 4.8 4.8  
Feeling nervous 4.8 2.4 7.2  
Feeling thirsty 0 16.6 16.6  
Feeling worried 0 4.8 4.8  
Trembling 9.5 0 9.5  
Rapid heartbeat 0 0 0  
Feeling sad 2.4 4.8 7.2  
Blurry vision 2.4 0 2.4  
Difficulty speaking 0 0 0  
Feeling happy 0 9.5 9.5  
Feeling flushed 2.4 2.4 4.8  
Sweating 2.4 0 2.4  
Urge to urinate 0 2.4 2.4  
Feeling hungry 0 7.1 7.1  
Salivation 0 2.4 2.4  
Feeling sure and confident 0 2.4 2.4  
Difficulty concentrating 0 2.4 2.4  
Difficulty breathing 0 0 0  
Feeling angry 0 4.8 4.8  
Feeling drowsy 4.8 14.3 19.1  
Feeling bad 2.4 0 2.4  
Feeling empty  2.4 0 2.4
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values was “feeling dizzy” (26.2% of the participants). Other
symptoms that stood out were “feeling thirsty,” which
correlated with high BGL in 16.7% of the participants, and
“feeling drowsy,” which correlated with high BGL in 14.3%
of the sample, as well as with low BGL in 4.8%.
Discussion
The results showed great variability in the capacity of
diabetic pre-adolescents to estimate their BGL. Some patients
showed acceptable accuracy in estimation, and some patients
showed very poor ability to estimate, similar to the results
obtained by Freund et al. (1986) with a sample of diabetic
adolescents.
The analysis of the estimations carried out indicates that
the participants showed a high number of BGL-estimation
errors (in fact, an average of 43.36% of the trials was
erroneous or clinically imprecise). Similarly, a greater number
of trials resulted in unperceived actual hypoglycemia or
hyperglycemia, as opposed to the trials in which the estimation
was a false hypo- or hyperglycemia. In addition, and of great
importance to diabetic care, a large number of trials resulted
in an inverse estimation, which represents the severe risk of
a patient taking management steps contrary to those that
should be taken, considering the actual BGL at that time.
There are a variety of possible explanations for the
elevated number of errors in unperceived hypo- and
hyperglycemia. One of these is to consider that the basic
error lies in the perception and recognition of the symptoms
that accompany these conditions, although this explanation
must be emphasized for those errors in unperceived
hyperglycemia when the actual BGL values are not extreme,
as moderate hyperglycemia frequently occurs with no
symptoms. On the other hand, an alternative explanation
has to do with the tendency found in diabetic patients to
“normalize their BGL” when reporting it; that is, the
estimation of their BGLs as normal or close to normal would
prevent them from recognizing hypo- and hyperglycemia
by not adequately appraising the symptoms and/or external
cues (Gil Roales-Nieto, 2000b), which is an obstacle to a
correct estimation.
The type of cue used by individuals to make correct
estimations is a relevant result for diabetic self-monitoring
because this can indicate guidelines that should be
emphasized in programs for diabetic intervention. Especially
relevant is the frequent use of internal cues in the estimation
trials (in almost 71% of the trials, we observed the use of
this kind of cue), which emphasizes the need for accuracy
training when using a type of cue that is difficult to dismiss
for people who are sensitive to perceivable changes within
themselves. Upon analyzing the cues used in the trials with
correct estimations, we observed that, when correctly
estimating hypoglycemia, participants based their judgments
primarily on internal cues, whereas correctly estimated
hyperglycemia was largely based on external cues. This may
reflect sensitivity to neuroglucopenic and/or adrenergic
symptoms produced during hypoglycemic episodes and
indicate the need to use external cues during hyperglycemia
that occurs asymptomatically. In the case of correct
euglycemia estimations, the individuals based their judgments
on the absence of symptoms or discomfort as well as on
external cues, which underscores the importance of the latter
as key s to diabetic self-management.
When focusing on the analysis of erroneous estimations,
we observe that, in the case of false hypoglycemia,
participants used internal cues or similar symptoms to those
used in correct hypoglycemia estimations, which could
indicate a generalization effect in the control of these
symptoms and make their functional discrimination more
difficult. Thus, a child who “feels dizzy” could blame it on
a hypoglycemic episode when, in fact, no such episode is
actually present. The child could be responding erroneously
to a symptom that could have been produced by something
other than a decrease in BGL.
These cases of incorrect estimations are impossible to
resolve if one only considers symptoms and not those
external cues that would indicate the slight probability of a
hypoglycemic episode (for example, being aware that a
recent meal, the absence of intense exercise, and the insulin
available in the blood would not signal that hypoglycemia
is developing). To be guided exclusively by symptoms can
cause errors in over-correction and weaken the correct
discriminative function of the symptom.
Another interesting result, which confirms the previous
analyses, is the fact that in the false hyperglycemia
estimations, we observed a greater use of internal cues when
compared to the estimations of correctly perceived
hyperglycemia. This indicates the probable presence of false
beliefs about symptoms that require special attention. Lastly,
regarding actual unperceived hypo- and hyperglycemia, the
data indicate that these errors occur when the individual
relates the absence of symptoms to normal BGL, another
false belief that is difficult to detect and is usually undetected
in psychological work with diabetic patients.
Regarding relationships between symptoms and extreme
BGL, the data indicate great differences between subjects,
in accordance with results from previous studies (Cox,
Gonder-Frederick, Pohl, & Pennebaker, 1983; Cox, Gonder-
Frederick, Antoun, Cryer, & Clarke, 1993; Freund et al.,
1986) that have noted this peculiarity. However, certain
symptoms seem to be more common than others, such as
“feeling dizzy,” which was related to low BGL in 26.4% of
the participants, or “being thirsty,” which was related to
high BGL in 16.7% of the individuals. These results do not
correspond to those obtained in other studies, such as that
by Freund et al. (1986). Another interesting finding is the
higher total number of relationships between symptoms and
high BGL than between symptoms and low BGL. This could
be due to the fact that the participants maintained high BGL
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during the study. This would facilitate the appearance of
more relationships between the symptoms and high BGL.
However, there are alternative explanations, the limitations
of which require considering the exact BGL to determine
whether just severe hyperglycemia would, by itself, explain
this phenomenon or whether other variables should be
considered. In sum, the results of this study show that the
majority of children, aged 9 to 14 years, with Type 1 diabetes
present adrenergic and neuroglucopenic symptoms associated
with episodes of hypoglycemia and that they are sensitive
to these symptoms, appraising them as warning signals.
However, numerous aspects of BGL estimation management
show deficiencies that can affect diabetic self-management,
as estimation errors are frequent and some of them could
have severe consequences. This shows that intervention, in
the form of BGL-discrimination training programs, is an
essential goal in diabetic care. Likewise, the results show
that the different functions performed by symptoms, internal,
and external cues, and their correct combination, is necessary
for an accurate BGL estimation at times when it is not
possible to perform an analysis.
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